The arc: from the exam room to the FDA

Rubin's trajectory isn't a change of mind, it's a change of altitude. She's a board-certified urologist, fellowship-trained in sexual medicine, and in 2022 she opened a practice that treats "comprehensive sexual medicine for all genders." She built her YouTube channel, in her own words, as a playlist "so that you can teach your friends and your doctors." That's the tell: from the start she wasn't building a following, she was building an army of informed patients to go correct their own physicians.

Then it escalated. The clinic educator of 2022 became the viral myth-buster of 2024, and by 2025 she was standing at an FDA roundtable begging them, out loud, to change the label on a drug. Her most recent video is titled, with a Hamilton wink, "The Room Where It Happened." She moved from trying to change one patient at a time to trying to change the rules for everyone. The advocacy isn't abstract for her, it's personal, and she tells the story that way:

I got to look at the FDA commissioner and I said, "Your box label tried to kill my mother." And I told the whole story of how it tried to kill my mother. (The Mel Robbins Podcast)

Insight: she is a system-changer who happens to make patient videos, not a content creator who wandered into advocacy. Treat her as a policy operator, because that's how she sees herself.

What she actually crusades on (it isn't testosterone)

If you know her from a testosterone clip, you'd guess wrong about her center of gravity. Her real obsession is genitourinary syndrome of menopause, local estrogen, and recurrent UTIs. Testosterone is real to her, but it's a fraction of what she talks about. Here's what her own corpus is made of, by share of videos that touch each theme:

Her single most-viewed video is "You Better Look 'Down There'" (190k). Her signature line is blunt to the point of alarming:

The term vaginal dryness is killing women. I mean it. It's actually killing women. (Doctors: Why your patients need hormones)

The logic underneath it: untreated GSM leads to recurrent UTIs, and in older women UTIs lead to sepsis and death. Local estrogen or DHEA cuts that recurrence by more than half. So to Rubin, "vaginal dryness" is a mortality problem wearing a quality-of-life disguise, and the gentle language is the enemy.

Insight: she reframed a nuisance into a killer. That single move is why physicians finally take GSM seriously, and almost nobody else in the space found it.

What actually makes her tick

• The male-medicine wedge, from the inside. Unlike almost anyone in menopause, she treats men too, erectile dysfunction, Viagra, "whiskey dick." So her double-standard argument isn't rhetorical, it's her Tuesday: "If a penis shriveled up at age 52, we'd probably have a vaccine sponsored by Pfizer." And she names what medicine does instead: "It's a castration event. If I cut your testicles off right now, you would have hot flashes, night sweats, osteoporosis, depression, low libido... and yet every woman over the age of 50" goes through exactly that, untreated.
• The cost argument, not just the compassion argument. Her own team published it: "If everybody in Medicare eligibility used vaginal estrogen, we would save Medicare between 6 and 22 billion dollars a year. They're in the ICU with sepsis. This is a huge economic and mortality problem, and no one cares." She knows the mortality case moves patients and the money case moves systems.
• The box-label as the named villain. The FDA warning on vaginal estrogen, stroke, clots, heart attack, probable dementia, is wrong for local dosing and scares women off a safe therapy. Her line on the damage: those labels "stopped decades of research... how can you prescribe something that is safe, but the box from the FDA says stroke, blood clots, heart attacks, dementia?" It's safe, she says, "for your great-grandmother in the nursing home... as little as $7 a month."
• Rage is the fuel, and she says so. "I am filled with rage because people are limiting their ability to have great sex, great relationships, and great health, because they aren't having access to all the information that they could." She frames the failure as a training gap, not stupidity: "your doctor wasn't trained, they're trying to save face, and 10 minutes is impossible."
• She destigmatizes with props and plain words. "When I started my practice, I bought two mirrors on Amazon, and I give women a mirror and I say, 'This is your labia majora, this is your clitoris.' Because women can't see it." Her recurring outrage: "the word clitoris today in 2026 does not exist in the checklist for what an OBGYN has to learn in their training." The comedy is the delivery system for the anatomy lesson.
• She has sticky lines ready. How long do you use vaginal hormones? "Till death do you part." Testosterone? "It's not a male hormone, a female hormone, it's just a hormone." Rub the estrogen in "like you would rub sunscreen on your face." She teaches in images, which is why she's quotable.

Her lines, verbatim (proof you watched)

A handful of exact quotes worth having in your pocket. Referencing one of these, accurately, is the fastest way to signal you've actually done the work.

Your box label tried to kill my mother. (to the FDA commissioner, via The Mel Robbins Podcast)

If a penis shriveled up at age 52, we'd probably have a vaccine sponsored by Pfizer. (Peter Attia, The Drive #348)

I don't know who decided that men get testosterone and women have estrogen. When you put everything in the same units, we are testosterone-driven beings, both of us. (Peter Attia, The Drive #348)

People like me are screaming from the rooftops, because we see it all day, every day. Our colleagues are seeing it, but they miss it. (unPAUSED with Mary Claire Haver)

Sourced from her long-form guest appearances (Mel Robbins, Peter Attia's The Drive, The Diary of a CEO, Haver's unPAUSED), verbatim from captions with obvious transcription noise cleaned.

Smart questions to ask her

These signal you've read her closely and want to push her thinking, not collect a soundbite.

1. You've made "vaginal dryness is killing women" your headline. When you say it to a skeptical physician audience instead of a patient audience, does the argument have to change, and where do you actually lose the doctors?
2. If the FDA pulled the box label tomorrow, what becomes the next bottleneck, prescriber knowledge, reimbursement, or patient fear? Which one actually moves the needle on treatment rates?
3. You treat men's and women's sexual health under one roof. What does seeing both back to back teach you that a gynecologist, or a urologist who only treats men, would never notice?
4. The Medicare 6-to-22-billion figure is your systems argument. Has any payer or policymaker actually engaged with the money case, or does it land differently than "it saves lives"?
5. Local estrogen is safe for breast cancer survivors per the data, but oncologists still resist. How do you move a doctor who's more worried about liability than about the evidence?
6. You went from a YouTube playlist "to teach your friends and your doctors" to the FDA roundtable. What did changing the system teach you that changing one patient at a time never did?
7. What's the claim you get accused of overstating most, and where do you think that criticism is actually fair?

How to praise her intelligently

Skip "you're so inspiring." Praise the specific moves, because that proves you actually watched, and that's the compliment she'll remember.

• "You reframed vaginal dryness from a quality-of-life nuisance into a mortality problem. That one move is why doctors finally take GSM seriously, and most people in this space never found it."
• "Putting men's and women's sexual health under one roof is the whole argument. When you say you'll prescribe Viagra without blinking but women can't get thirteen-dollar vaginal estrogen, nobody can un-see the double standard."
• "You made the cost case, not just the compassion case. The Medicare number is what gets you into the rooms that compassion alone can't."
• "You'll stand in front of the FDA and say 'my mom and family deserve better' and mean it. That's not a brand, that's a person, and it reads."
• "You destigmatize by being funny about anatomy instead of solemn about it. 'The clitoris is not a bad word' does more work than a lecture ever could."

How to actually become her friend

You're not a fan, you're a peer. You run a women's-health platform, you live the science you teach (your own HRT, testosterone, and APOE4 story), and you're building in her exact lane. Lead with that.

• Approach as a colleague, not an audience member. One sentence on what you're building (SmartStrongAlive, your first-person hormone story) puts you beside her, not below her.
• Give before you ask. Send something genuinely useful to her advocacy: a clean audience insight about what finally made women try local estrogen, or a crisp explainer of the box-label science she can reuse. Usefulness earns a reply; praise doesn't.
• Engage her arguments, not her headlines. Reference the Medicare figure, the "safe for breast cancer patients" data, the box-label mechanism. Commenting on the detail proves you listen.
• Be useful to her mission. She wants the box label gone and women treated. Your platform amplifies that. Offer reciprocity, share her advocacy to your audience, or a guest swap, framed as advancing the cause you both care about.
• Use the Casperson bridge. She and Kelly Casperson are close collaborators, and you've already built the Casperson relationship groundwork. A warm introduction through that shared orbit (ISSWSH, the Menopause Society, the Haver/Attia/Mel Robbins guest network) beats any cold DM.
• One earned compliment, then move on. Gushing marks you as a fan. One specific, accurate observation marks you as a peer, and peers become friends.